Long-term ECG monitoring
Authors:
Veronika Bulková
Authors place of work:
Centrum kardiovaskulární péče, Neuron Medical, Brno
; MDT – Mezinárodní centrum pro telemedicínu, Brno
Published in the journal:
Vnitř Lék 2021; 67(1): 16-21
Category:
Hlavní téma
Summary
ECG recording represents an essential method for the diagnosis of heart rhythm disturbances. Long-term monitoring helps to identify arrhythmias that have not been detected by means of standard 12-lead ECG or 24-48 hour ECG Holter. With time, ECG monitoring facilities improve, the ECG recorders are becoming smaller, and the recording time is prolonging. At present, continuous ECG recording is generally available. Smart watches and fitness bracelets further expand monitoring options in patients with known or suspected arrhythmia. Individual type and frequency of symptoms remain the most significant criterion for the selection of suitable ECG recorder and recording time.
Keywords:
long-term ecg monitoring – telemedicine.
Zdroje
1. Brugada P, Gursoy S, Brugada J et al. Investigation of palpitations. Lancet 1993; 341: 1254–1258.
2. Locati ET, Moya A, Oliveira M et al. External prolonged electrocardiogram monitoring in unexplained syncope and palpitations: results of the SYNARR‑Flash study. Europace 2016; 18: 1265–1272.
3. Reiffel JA, Schulhof E, Joseph B et al. Optimum duration of transtelephonic ECG monitoring when used for transient symptomatic epizode detection. J Electrocardiol 1991; 24: 165–168.
4. Brignole M. Syncope, management from emergency department to hospital. J Am Coll Cardiol 2008; 51: 284–287.
5. Soteriades ES, Evans JC, Larson MG et al. Incidence and prognosis of syncope. N Engl J Med 2002; 347: 878–885.
6. Middlekauff HR, Stevenson WG, Saxon LA. Prognosis after syncope: impact of left ventricular function. Am Heart J 1993; 125: 121–127.
7. Brignole M, Moya A, de Lange FJ et al. 2018 ESC Guidelines of the diagnosis and management of syncope. Eur Heart J 2018; 39: 1883–1948.
8. Bass EB, Curtiss EI, Arena VC et al. The duration of Holter monitoring in patients with syncope: is 24 hours enough? Arch Intern Med 1990; 150: 1073–1078.
9. Linzer M, Yang EH, Estes NA. Diagnosing syncope. Part 1: Value of history, physical examination, and electrocardiography. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 1997; 126: 989–996.
10. Gula LJ, Krahn AD, Massel D et al. External loop recorders: determinants of diagnostic yield in patients with syncope. Am Heart J 2004; 147: 644–648.
11. Locati ET, Vecchi AM, Vargiu S et al. Role of extended external loop recorders for the diagnosis of unexplained syncope, pre‑syncope, and sustained palpitations. Europace 2014; 16: 914–922.
12. Locati ET, Moya A, Oliveira M et al. External prolonged electrocardiogram monitoring in unexplained syncope and palpitations: results of the SYNARR‑Flash study. Europace 2016; 18: 1265–1272.
13. Frangini P, Cechin F, Jordao L et al. How revealing are insertable loop recorders in pediatrics? Pacing Clin Electrophysiol 2008; 31: 338–343.
14. Krahn AD, Klein GJ, Yee R et al. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 2001; 104: 46–51.
15. Podoleanu C, DaCosta A, Defaye P et a. Early use of an implantable loop recorder in syncope evaluation: a randomized study in the context of the French healthcare system (FRESH study). Arch Cardiovasc Dis 2014; 107: 546–552.
16. Sulke N, Sugihara C, Hong P et al. The benefit of a remotely monitored implantable loop recorder as a first line investigation in unexplained syncope: The EaSyAS II trial. Europace 2016;18: 912–991.
17. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983–988.
18. Adams HP Jr, Biller J. Classification of subtypes of ischemic stroke: history of the trial of org 10172 in acute stroke treatment classification. Stroke 2015; 46: e114–117.
19. Kirchhof P, Benussi S, Kotecha D et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC), developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC, endorsed by the European Stroke Organisation (ESO). Europace 2016; 18: 1609–1678.
20. Powers WJ, Rabinstein AA, Ackerson T et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 2018; 49(3): e46–e110.
21. Wein T, Lindsay MP, Cote R et al. Canadian stroke best practice recommendations:
22. Secondary prevention of stroke, sixth edition practice guidelines, update 2017. Int J Stroke 2018; 13(4): 420–443.
Štítky
Diabetologie Endokrinologie Interní lékařstvíČlánek vyšel v časopise
Vnitřní lékařství
2021 Číslo 1
- Není statin jako statin aneb praktický přehled rozdílů jednotlivých molekul
- Testování hladin NT-proBNP v časné diagnostice srdečního selhání – guidelines ESC
- Cinitaprid – v Česku nová účinná látka nejen pro léčbu dysmotilitní dyspepsie
- Pregabalin je účinné léčivo s příznivým bezpečnostním profilem pro pacienty s neuropatickou bolestí
- Moje zkušenosti s Magnosolvem podávaným pacientům jako profylaxe migrény a u pacientů s diagnostikovanou spazmofilní tetanií i při normomagnezémii - MUDr. Dana Pecharová, neurolog
Nejčtenější v tomto čísle
- Horečka nejasného původu
- Dlouhodobá EKG monitorace
- Následná péče po prodělaném covidu-19 a její úskalí
- EMPEROR reduced – empagliflozin u nemocných se srdečním selháním se sníženou ejekční frakcí